The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Obesity is a chronic disease influenced by genetics, hormones, and metabolism, not merely overeating. Disruptions in leptin ...

Hegseth shared a report from the Military Times on a study from the American Security Project, which found that over ...

Secretary of Defense Pete Hegseth sounded the alarm over the readiness of reserve troops after a study found that over ...

For true pet parents, life revolves around keeping their furry friends happy and healthy. But if meals aren’t portioned to ...

Health360 focusses on India's obesity epidemic and Prime Minister Modi's recent call to tackle it. Experts discuss the rise of weight loss drugs, the importance of nutrition education, and the need ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

ANTIBIOTICS are one of the miracles of modern medicine. The drugs have transformed the treatment of deadly bacterial ...

According to a study, India ranks just behind US and China in obesity rates, with 30 million adults overweight or obese, says ...

The study, conducted by researchers in Finland, found that children who took antibiotics before the age of two were 20 per ...

The fifth edition of “Health of the Nation 2025” (HoN-2025) by the Apollo Hospitals commenced with a clear message: “Don’t wait for symptoms, rather make preventive health your priority”.